ANGPTL8 Gene Polymorphism rs2278426 Is Related to Carotid Intima–Media Thickness in T2DM

References

• Kahn SE. Clinical review 135: the importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab. 2001;86(9):4047–4058. doi:10.1210/jcem.86.9.7713
   PubMed Web of Science ®Google Scholar
• Carracher AM, Marathe PH, Close KL. International Diabetes Federation 2017. J Diabetes. 2018;10(5):353–356. doi:10.1111/1753-0407.12644
   PubMed Web of Science ®Google Scholar
• NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants [published correction appears in Lancet. 2017 Feb 4;389(10068):e2]. Lancet. 2016;387(10027):1513–1530. doi:10.1016/S0140-6736(16)00618-8.
   PubMed Web of Science ®Google Scholar
• Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287(19):2570–2581. doi:10.1001/jama.287.19.2570
   PubMed Web of Science ®Google Scholar
• Vamos EP, Millett C, Parsons C, et al. Nationwide study on trends in hospital admissions for major cardiovascular events and procedures among people with and without diabetes in England, 2004–2009. Diabetes Care. 2012;35(2):265–272. doi:10.2337/dc11-1682
   PubMedGoogle Scholar
• Pignoli P, Tremoli E, Poli A, et al. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74(6):1399–1406. doi:10.1161/01.cir.74.6.1399
   PubMed Web of Science ®Google Scholar
• Wikstrand J. Methodological considerations of ultrasound measurement of carotid artery intima-media thickness and lumen diameter. Clin Physiol Funct Imaging. 2007;27(6):341–345. doi:10.1111/j.1475-097X.2007.00757.x
   PubMed Web of Science ®Google Scholar
• Bots ML, Mulder PG, Hofman A, et al. Reproducibility of carotid vessel wall thickness measurements. The Rotterdam Study. J Clin Epidemiol. 1994;47(8):921–930. doi:10.1016/0895-4356(94)90196-1
   PubMedGoogle Scholar
• Persson J, Formgren J, Israelsson B, et al. Ultrasound-determined intima-media thickness and atherosclerosis. Direct and indirect validation. Arterioscler Thromb. 1994;14(2):261–264. doi:10.1161/01.atv.14.2.261
   PubMedGoogle Scholar
• Espeland MA, Craven TE, Riley WA, et al. Reliability of longitudinal ultrasonographic measurements of carotid intimal-medial thicknesses. Asymptomatic Carotid Artery Progression Study Research Group. Stroke. 1996;27(3):480–485. doi:10.1161/01.str.27.3.480
   PubMed Web of Science ®Google Scholar
• Coskun U, Yildiz A, Esen OB, et al. Relationship between carotid intima-media thickness and coronary angiographic findings: a prospective study. Cardiovasc Ultrasound. 2009;7:59. doi:10.1186/1476-7120-7-59
   PubMed Web of Science ®Google Scholar
• Geroulakos G, O’Gorman DJ, Kalodiki E, et al. The carotid intima-media thickness as a marker of the presence of severe symptomatic coronary artery disease. Eur Heart J. 1994;15(6):781–785. doi:10.1093/oxfordjournals.eurheartj.a060585
   PubMed Web of Science ®Google Scholar
• Crouse JR, Toole JF, McKinney WM, et al. Risk factors for extracranial carotid artery atherosclerosis. Stroke. 1987;18(6):990–996. doi:10.1161/01.str.18.6.990
   PubMed Web of Science ®Google Scholar
• Poli A, Tremoli E, Colombo A, et al. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients. A new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects. Atherosclerosis. 1988;70(3):253–261. doi:10.1016/0021-9150(88)90176-1
   PubMed Web of Science ®Google Scholar
• Tell GS, Howard G, McKinney WM. Risk factors for site specific extracranial carotid artery plaque distribution as measured by B-mode ultrasound. J Clin Epidemiol. 1989;42(6):551–559. doi:10.1016/0895-4356(89)90151-0
   PubMedGoogle Scholar
• Salonen R, Salonen JT. Progression of carotid atherosclerosis and its determinants: a population-based ultrasonography study. Atherosclerosis. 1990;81(1):33–40. doi:10.1016/0021-9150(90)90056-o
   PubMed Web of Science ®Google Scholar
• Salonen R, Salonen JT. Carotid atherosclerosis in relation to systolic and diastolic blood pressure: kuopio Ischaemic Heart Disease Risk Factor Study. Ann Med. 1991;23(1):23–27. doi:10.3109/07853899109147926
   PubMed Web of Science ®Google Scholar
• Taskinen MR, Borén J. New insights into the pathophysiology of dyslipidemia in type 2 diabetes. Atherosclerosis. 2015;239(2):483–495. doi:10.1016/j.atherosclerosis.2015.01.039
   PubMed Web of Science ®Google Scholar
• Taskinen MR. Type 2 diabetes as a lipid disorder. Curr Mol Med. 2005;5(3):297–308. doi:10.2174/1566524053766086
   PubMed Web of Science ®Google Scholar
• Chapman MJ, Ginsberg HN, Amarenco P, et al. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J. 2011;32(11):1345–1361. doi:10.1093/eurheartj/ehr112
   PubMed Web of Science ®Google Scholar
• Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24(4):683–689. doi:10.2337/diacare.24.4.683
   PubMed Web of Science ®Google Scholar
• Nichols GA, Hillier TA, Erbey JR, et al. Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. Diabetes Care. 2001;24(9):1614–1619. doi:10.2337/diacare.24.9.1614
   PubMed Web of Science ®Google Scholar
• Ma X, Lu R, Gu N, et al. Polymorphisms in the glucagon-like peptide 1 receptor (GLP-1R) gene are associated with the risk of coronary artery disease in chinese han patients with type 2 diabetes mellitus: a case-control study. J Diabetes Res. 2018;2018:1054192. doi:10.1155/2018/1054192
   PubMedGoogle Scholar
• Ezhilarasi K, Dhamodharan U, Vijay V. BSMI single nucleotide polymorphism in vitamin D receptor gene is associated with decreased circulatory levels of serum 25-hydroxyvitamin D among micro and macrovascular complications of type 2 diabetes mellitus. Int J Biol Macromol. 2018;116:346–353. doi:10.1016/j.ijbiomac.2018.05.026
   PubMedGoogle Scholar
• Hanson RL, Leti F, Tsinajinnie D, et al. The Arg59Trp variant in ANGPTL8 (betatrophin) is associated with total and HDL-cholesterol in American Indians and Mexican Americans and differentially affects cleavage of ANGPTL3. Mol Genet Metab. 2016;118(2):128–137. doi:10.1016/j.ymgme.2016.04.007
   PubMedGoogle Scholar
• Liu J, Yagi K, Nohara A, et al. High frequency of type 2 diabetes and impaired glucose tolerance in Japanese subjects with the angiopoietin-like protein 8 R59W variant. J Clin Lipidol. 2018;12(2):331–337. doi:10.1016/j.jacl.2017.12.011
   PubMed Web of Science ®Google Scholar
• Dang F, Wu R, Wang P, et al. Fasting and feeding signals control the oscillatory expression of angptl8 to modulate lipid metabolism. Sci Rep. 2016;6:36926. doi:10.1038/srep36926
   PubMedGoogle Scholar
• Zhang R, Abou-Samra AB. A dual role of lipasin (betatrophin) in lipid metabolism and glucose homeostasis: consensus and controversy. Cardiovasc Diabetol. 2014;13:133. doi:10.1186/s12933-014-0133-8
   PubMed Web of Science ®Google Scholar
• Ren G, Kim JY, Smas CM. Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism. Am J Physiol Endocrinol Metab. 2012;303(3):E334–51. doi:10.1152/ajpendo.00084.2012
   PubMed Web of Science ®Google Scholar
• Stephens JM. RIFL aims to be a new player in lipid metabolism. Am J Physiol Endocrinol Metab. 2012;303(3):E332–3. doi:10.1152/ajpendo.00169.2012
   PubMedGoogle Scholar
• Zhang R. Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels. Biochem Biophys Res Commun. 2012;424(4):786–792. doi:10.1016/j.bbrc.2012.07.038
   PubMed Web of Science ®Google Scholar
• Rong Guo X, Li Wang X, Chen Y, et al. ANGPTL8/betatrophin alleviates insulin resistance via the Akt-GSK3β or Akt-FoxO1 pathway in HepG2 cells. Exp Cell Res. 2016;345(2):158–167. doi:10.1016/j.yexcr.2015.09.012
   PubMed Web of Science ®Google Scholar
• Hu H, Sun W, Yu S, et al. Increased circulating levels of betatrophin in newly diagnosed type 2 diabetic patients. Diabetes Care. 2014;37(10):2718–2722. doi:10.2337/dc14-0602
   PubMed Web of Science ®Google Scholar
• Chen X, Lu P, He W, et al. Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance. J Clin Endocrinol Metab. 2015;100(1):E96–100. doi:10.1210/jc.2014-2300
   PubMed Web of Science ®Google Scholar
• Ebert T, Kralisch S, Hoffmann A, et al. Circulating angiopoietin-like protein 8 is independently associated with fasting plasma glucose and type 2 diabetes mellitus. J Clin Endocrinol Metab. 2014;99(12):E2510–7. doi:10.1210/jc.2013-4349
   PubMed Web of Science ®Google Scholar
• Chen CC, Susanto H, Chuang WH, et al. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function. Cardiovasc Diabetol. 2016;15:3. doi:10.1186/s12933-015-0326-9
   PubMedGoogle Scholar
• Wang YY, Zhang D, Jiang ZY, et al. Positive association between betatrophin and diabetic retinopathy risk in type 2 diabetes patients. Horm Metab Res. 2016;48(3):169–173. doi:10.1055/s-0035-1550009
   PubMedGoogle Scholar
• Yin Y, Ding X, Peng L, et al. Increased serum ANGPTL8 concentrations in patients with prediabetes and type 2 diabetes. J Diabetes Res. 2017;2017:8293207. doi:10.1155/2017/8293207
   PubMed Web of Science ®Google Scholar
• Shimamura M, Matsuda M, Kobayashi S, et al. Angiopoietin-like protein 3, a hepatic secretory factor, activates lipolysis in adipocytes. Biochem Biophys Res Commun. 2003;301(2):604–609. doi:10.1016/s0006-291x(02)03058-9
   PubMed Web of Science ®Google Scholar
• Ye J, Qin Y, Wang D, et al. The relationship between circulating ANGPTL8/betatrophin concentrations and adult obesity: a meta-analysis. Dis Markers. 2019;2019:5096860. doi:10.1155/2019/5096860
   PubMed Web of Science ®Google Scholar
• El-Lebedy D. Interaction between endothelial nitric oxide synthase rs1799983, cholesteryl ester-transfer protein rs708272 and angiopoietin-like protein 8 rs2278426 gene variants highly elevates the risk of type 2 diabetes mellitus and cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):97. doi:10.1186/s12933-018-0742-8
   PubMedGoogle Scholar
• Fu Z, Berhane F, Fite A, et al. Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity. Sci Rep. 2014;4:5013. doi:10.1038/srep05013
   PubMed Web of Science ®Google Scholar
• Espes D, Martinell M, Carlsson PO. Increased circulating betatrophin concentrations in patients with type 2 diabetes. Int J Endocrinol. 2014;2014:323407. doi:10.1155/2014/323407
   PubMed Web of Science ®Google Scholar
• Trebotic LK, Klimek P, Thomas A, et al. Circulating betatrophin is strongly increased in pregnancy and gestational diabetes mellitus. PLoS One. 2015;10(9):e0136701. doi:10.1371/journal.pone.0136701
   PubMed Web of Science ®Google Scholar
• Ebert T, Kralisch S, Wurst U, et al. Betatrophin levels are increased in women with gestational diabetes mellitus compared to healthy pregnant controls. Eur J Endocrinol. 2015;173(1):1–7. doi:10.1530/EJE-14-0815
   PubMed Web of Science ®Google Scholar
• Luo D, Chen X, Yang W, et al. Angiopoietin-like 8 improves insulin resistance and attenuates adipose tissue inflammation in diet-induced obese mice. Exp Clin Endocrinol Diabetes. 2020;128(5):290–296. doi:10.1055/a-0725-7897
   PubMedGoogle Scholar
• Mamputu JC, Desfaits AC, Renier G. Lipoprotein lipase enhances human monocyte adhesion to aortic endothelial cells. J Lipid Res. 1997;38(9):1722–1729.
   PubMedGoogle Scholar
• Mamputu JC, Levesque L, Renier G. Proliferative effect of lipoprotein lipase on human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2000;20(10):2212–2219. doi:10.1161/01.atv.20.10.2212
   PubMedGoogle Scholar
• Kovrov O, Kristensen KK, Larsson E, et al. On the mechanism of angiopoietin-like protein 8 for control of lipoprotein lipase activity. J Lipid Res. 2019;60(4):783–793. doi:10.1194/jlr.M088807
   PubMed Web of Science ®Google Scholar
• Abu-Farha M, Melhem M, Abubaker J, et al. ANGPTL8/Betatrophin R59W variant is associated with higher glucose level in non-diabetic Arabs living in Kuwaits. Lipids Health Dis. 2016;15:26. doi:10.1186/s12944-016-0195-6
   PubMed Web of Science ®Google Scholar
• Ghasemi H, Karimi J, Khodadadi I, et al. Association between rs2278426 (C/T) and rs892066 (C/G) variants of ANGPTL8 (betatrophin) and susceptibility to type2 diabetes mellitus. J Clin Lab Anal. 2019;33(1):e22649. doi:10.1002/jcla.22649
   PubMed Web of Science ®Google Scholar